GAVATIQ, created in 2015 (Czech Republic), from 2757 sister brands and 17478 competing brands. The GAVATIQ brand is owned by SANOFI, a company listed in Paris. The ISIN, the company's International Securities Identification Number, is FR0000120578. GAVATIQ belongs to the Drug Manufacturers business sector.